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Chapter I Introduction
Although it is well known that streptomycin (SM) and isonicotinic acid
hydrazide (lNH) are for themselves the most powerful drugs for tuberculosis, the
combined use of these two is rather exceptional in practice. In Japan, the com-
monest regimen for the chemotherapy of tuberculosis is the combination of SM
and PAS, although the combined use of three drugs, SM, PAS and INH is be-
coming more and more popular nowadays. One of the reasons of this exceptional
use of SM plus INH may be to put at least one of the most powerful drugs aside
for such an urgent occasion as surgical operation. The other reason may be that
PAS is considered to be most useful for preventing the development of the drug-
resistant bacilli, and, therefore, the withdrawal of PAS from the combination of
drugs is thought not to be rational.
However, it may be of some value to use these two powerful drugs, SM and
INH, in combination in order to obtain rapid and appreciable effect for the treat-
ment of tuberculosis without PAS, because the latter drug has rather strong side
effect to the gastrointestinal and hepatic functions.
Ilavskyl), Mackaness2 ), and Hobby 3) reported that the growth of tubercle
bacillus was inhibited in vitro in the presence of SM and INH combined even in
such low doses that each drug alone did not inhibit its growth. Singh and
Mitchison4 ) found that the combined use of SM and INH, at the growth-inhibiting
concentration of each drug, acted tuberculocidally in vitro. On the other hand,
Ebina5 ) said that the effect of SM, when used in combination with INH, became
obscure by the effect of INH, and the additive effect of the two drugs was not
determined. However, as for the prevention of the development of drug-resistant




Piechand et a16 ) examined the effect of combined use of SM and INH on ginea
pig tuberculosis, and found no significant difference between the effect of the
combination and that of single drug used separately. Freerksen7) reached the
similar conclusion observing the survival time of rabbits infected with virulent
tubercle bacilli. Gernez-Rieux8 ), on the other hand, reported the synergistic effect
of the combined chemotherapy with SM and INH on rabbit tuberculosis.
Clinically, a detailed statistics was presented by the Veterans Administration9 \
that SM-INH therapy, in the minimal and moderately advanced cases, showed
excellent results, but a report from Ryo-Ken10 ) indicated that this therapy was
less effective than the IHN-PAS therapy.
Thus, experimental and clinical results hitherto obtained seem to be contra·
dictory. The present writer carried out some experiments on the effect of com-
bined use of SM and INH on mouse tuberculosis, especially to see whether or not
the effect of the combination is significantly better than that of single drug used
separately. In addition, clinical results of 223 patients treated with combination
of SM and INH will be reported in comparison with the results of the combination
of SM, INH and PAS.
Chapter II Animal experiments
a) The effect of the combined use of 8M and INH on the survival time
of mice.
(1) Materials and methods
Seventy mice of dd strain, each weighing ca. 20 g, were used. They were
divided into seven groups and all were inoculated into the tail vein with 0.5 mg
(wet weight) saline suspension of two weeks old human tubercle bacilli of Kurono
strain (strongly virulent to mice) grown on glycerol broth. From the next day
of inoculation each group was treated as follows:
Group I: SM 20 rig body weight (daily)
II: INH 1 rig (daily)
III: SM 20 rig + INH 1 i'lg (daily)
IV: SM 10 rig (daily)
V: INH 0.5 rig (daily)
VI: SM 10 rig + INH 0.5 r/g (daily)
VII: non-treated control
Treatments were continued until a half of mice died in each group. SM and
INH were disolved with distilled water so as to make each dose described above
was contained in 0.2 ml of the solution. SM was injected subcutaneously into the
hack of mice and INH was administered per os using a metal catheter.
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(2) Results
Survival rates and days of each group were shown in Fig. 1. A verage survival
day was: 1st group 18.7, 2nd group 20, 3rd group 26.5, 4th group 17.6, 5th group
17.5, 6th group 19.3 and 7th group (control) 15.5. It seems that the combination
of 20 rig SM plus 1 rig INH (3rd group) showed an apparently better effect on
the survival time of mice than any regimen of single chemotherapy, but the
combination of 10 rig SM plus 0.5 rig INH (6th group) had no such signifficant
effectiveness.
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Fig. 1. Survival time of mice.
b) Evaluation of the combined chemotherapy of 8M and INH by means of
the quantitative cultivation of tubercle bacilli from organs.
(1) Materials and methods
Six groups of mice, each consisting of ten, were inoculated intravenously with
tubercle bacilli (Kurono strain), and treated from the next day of inoculation.








SM 20 rig body weight
INH 1 rig










SM 20 rlg+ INH 1 rig
Three mice from each group were sacrificed 3,6 and 9 weeks after the onset
of treatment. Quantitative cultivation of bacilli from the lung, liver and spleen
was carried out as described below, and the macroscopic changes of each organ
were noted.
Quantitative cultivation: A piece of organ was homogenated, and 10, 100, and
1000 fold dilutions of original homogenates were made with 6% NaOH solution.
0.1 ml of these homogenates were inoculated on the surface of 3% Ogawa's solid
egg media. After 4 weeks' cultivation at 37°C, the number of colonies was
counted. The estimated viable count of each organ was indicated as the number
per 1 mg of the organ.
Using the cultures obtained from the lung homogenates, drug-resistance was
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Fig. 2. Results of quantitative cultivation (Lung).
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tested using the Ogawa's media containing 1, 10 and 100 rlml of SM or 0.1, 1
and 10 rlml of INH.
(2) Results
Fig. 2, 3 and 4 show the number of colonies obtained from the lun.g, liver
and spleen in histogram, respectively.
From these results it seems that the combined use of SM and INH reduced
the number of viable bacilli in organs more markedly than the single chemotherapy.
Table 1 shows the results of gross findings of organs.
From the result it may be easily known that the gross pathological changes
were reduced more markedly by the combined therapy than by the single drug
treatment.
Results of the tests of drug-resistance of bacilli were shown in Table 2. As
for INH, no increase of resistance was seen in all bacilli tested. In the single
SM treatment incomplete resistance to 10 rIml SM was seen in both groups of
0.001 mg and 0.01 mg.
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Fig. 4. Results of quantitative cultivation (Spleen).
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Note: +···a few disseminated tubercles.
*.. ·numerous disseminated tubercles.
-Htoo ·confluent tubercles and large caseous masses.
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Table 2. Results of the drug-resistance test of the bacilli obtained from
lungs of mice treated with drugs.
Inoculum
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I Incomplete resistance to 10 'Y Iml
SM in 1 of 3 animals
Sensitive
Sensitive
From the experimental results described in this chapter, it may be concluded
that SM and INH, when used in combination, can act more effectively on tuber-
culosis induced in dd strain mice than they do when used separately.
Chapter III Clinical observations
Considering the experimental results described above, it was inferred that the
combined use of SM and INH might be useful for patients, especially when the
side effect of PAS was expected. Clinical observations using this combination of
drugs were performed in comparison with the other combined therapy which
consisted of three drugs including PAS.
410 patients were treated with the following three types of chemotherapy for
6-20 months.
1) SM-INH therapy (223 cases): SM Ig twice a week, INH 0.6 mg/kg daily,
but in some cases of exudative form, SM 19 daily during the first 7-10 days, and
thereafter twice a week.
II) Three drugs therapy (134 cases): SM 1 g twice a week, INH 0.6 mg/kg
and PAS 10 g daily.
III) Three drugs therapy (53 cases): SM Ig and INH 0.6 mg/kg twice a week
and PAS 10 g daily.
The types of the disease classified by the scheme of the National Tuber-
culosis Association CU. S. A.) at the onset of the treatment were shown in Table 3.


























Table 4. Body weight changes of the patients.
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7 (5.2%) 4 (7.5% ) 11 (5.9%)
Unchanged I 13 (5.8% ) 23 (17.1%) 10 (18.9% ) 33 (17.6%)I






8-10 kg I 25 (92.4% ) 14 (76.9%) ~ j (73.6%) 19 (76.5%)
I10-12 kg 29 8 12










134 t 53 1 187
- -- --
Note: 6-20 months observation
a) Body weight
As shown in Table 4, in SM-INH therapy, the rate of increase of body weight
was 92.4%, and about the two thirds of patients showed the increase over 10 kg.
While in cases of three drugs therapy the rate of increase was 76.5%, and the
increase of weight was under 10 kg in the majority of them. From the point of
view of body weight, the SM-INH therapy was apparently better than the three
drugs therapy.
b) Erythrocytes sedimentation rate (ESR)
It was found that SM-INH therapy was the best in the improvement of ESR,
among three types of therapies examined.
c) Tubercle bacilli in sputa
Results were classified by the standard of Ryo-Ken (Tuberculosis Research
Committee, supported by the Ministry of Health and Welfare) and were shown
in Table 5. It seems that the three drugs therapy was better than the SM-INH






INH daily intermittent Total
I
----------
Converted negative 143 (81.7%) 52 (92.9%) 22 (84.6%) 74 (90.3%)
The jDecreased 27 (15.4%) 1 ( 1.8%) 0 1 ( 1.2%)
number Unchanged 5 ( 2.9%) 2 ( 3.6%) 4 (15.4%) 6 ( 7.3%)of the
bacilli Increased 0 1 ( 1.8%) 0 1 ( 1.2%)
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therapy from the view-point of the negative conversion rate of the bacilli. The
three drugs therapy of INH daily was much better than that of INH intermittently.
d) Development of drug-resistant tubercle bacilli.
In the present investigation the drug-resistance means that when the bacilli
grow in vitro in the concentration of more than 10 rlml of SM or PAS, or 1 rlml
of INH. As seen in Table 6, it may be worthy of note that the development of
drug-resistance was more frequent in the SM- INH therapy than the three drugs
therapy of INH daily, and the worst was the three drugs therapy of INH inter-
mittently.





INH daily Totalintermittent i
------------
IPositive culture before 175 56 26 82treatment
IFailed to convert 32 (18.3%) 4 (7.1% ) 4 (15.4% ) I 8 ( 9.8%)
negative i
!
Drug-resistance {( 5.1%)* 0 {( 7.7%)* I {( 2.4%)*developed 9 (28.1%)** 2 (50.0% )** 2 (25.0% )**
The percentage value of the asterisk (*) of the drug-resistant group shows the rate of
drug-resistance in the positive cases at the onset of the treatment, and that of the two
asterisks (**) shows the rate of drug-resistance in the cases which failed to convert
negative.








































e) Roentgenographic findings of the chest
The changes of the X-ray findings were indicated by the formula of Gaku-Ken
(Tuberculosis Research Committee, supported by Japan Education Ministry). As
shown in Table 7, the marked improvement was seen more frequently in the
group of SM-INH than in the three drugs therapies, whereas the worsening seemed




The changes of the cavity in the X-ray films were classified as follows:
(i) Disappeared: Transparence of the cavity completely disappeared remaining
linear or strangular or small round shadows of which diameter was the same or
less than the sum of the thickness of original cavity wall, (ii) Filled-in: Trans-
parence of the cavity completely disappeared, but the diameter of the concentrated
shadow was more than the sum of the thickness of the original cavity wall,
(iii) Reduced: Transparence of the cavity did not disappear, but the outer dia-
meter of the lesion became smaller than the half of the original cavitary thickness,
(iv) Unchanged: Transparence of the cavity did not disappear, and the outer
diameter of the cavity was more than half of the original cavitary thickness,
(v) Enlarged: Transparence did not disappear, and the cavity enlarged.
The results were shown in Table 8. The rate of disappearance of the cavity
was higher in the SM-INH therapy (63.5%) than in the three drugs therapy
(49.6%).










INH daily intermittent Total
- ----------
--- -- ------ -
66 (63.5%) 55 (51.4%) 12 (42.9%)
I
67 (49.6%)
1 ( 1.0%) 4 ( 3.7%) 1 ( 3.6%) 5 ( 3.7%)
31 (29.8%) 25 (23.4%) 10 (35.7%) 35 (25.9%)
3 ( 2.9%) 22 (20.6%) 4 (14.3%) 26 (19.3%)
3 ( 2.9%) 1 ( 0.9%) 1 ( 3.6%) 2 ( 1.5%)
------------ - - -
I
104 107 28 135
------------
g) Summarized clinical evaluations of the three different therapies.
Evaluations were done according to the standard formula presented by
Gaku-Ken. As seen in Table 9, the SM-INH therapy was the best in the minimal
and the moderately advanced cases, but in the far advanced cases the rate of
worsening was higher in the SM-INH therapy than in the three drugs therapies.
h) Side reactions
A few cases of allergic or idiosyncrasic reaction to one of these drugs were
seen in each group of treatment. Besides, some cases of tinnitus and bradyacusia
by SM, and peripheral neuritis by INH were also seen in all groups. The most
remarkable problem was the side reaction induced by PAS such as anorexia or
gastrointestinal symptoms. Twenty three cases were forced to give up the use
of PAS in the course of the three drugs therapy. And there were many patients
who complained anorexia, though the discontinuation of the drug was not neces-
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Table 9. Summarized clinical evaluation.
a) SM+INH
Markedly Moderately I Slightly Unchanged Worsened Totalimproved improved improved
Minimal 16 6
I
5 0 0 27
Moderately 92 36 34 3 0 165
advanced
Far advanced 0 6 11 7 7 31
---_ ..-
Total 108 48 50 10 7 223
b) SM+PAS+INH (INH daily)
Minimal 21 13 17 16
I
0 67
Moderately 20 5 20 14 0 59
advanced
Far advanced 0 0 2 6 0 8





c) SM+PAS+INH (INH intermittent).
Minimal 6 5 6 5 0 22
Moderately 5 4 10 5 0 24
advanced
Far advanced 0 2 1 2 2 7
Total 11 11 17 12 2 53
sary. The medication was used to stop for three days before the monthly culture
of sputa. One hundred and two patients among 187 who were treated with three
drugs increased their appetite in these non-medicated days, while only one case
of SM-INH therapy group was so. This fact may indicate the masked side effect
of PAS, i.e., the unconscious decrease of appetite during PAS administration on
more than half of the patients.
Chapter IV Conclusion
The results of the animal experiments in the present investigation suggest
that the combined use of SM-INH exert a more active effect on tuberculosis
than used separately.
From the clinical investigation, it may be said that 0) body weight, X-ray
findings and cavity were improved by SM-INH therapy much better than SM-
INH-PAS therapy; and (2) from the view-points of the bacillus findings in sputa
and the development of drug-resistance, SM-INH therapy was not so good as
three drugs treatment in the negative conversion rate, and, therefore, more
abundant appearance of the drug-resistance was noticed in the former treatment.
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This also may mean that the worsening of symptoms was more apparent in far
advanced cases treated with SM-INH than three drugs combined. However, as
the early negative conversion can be expected in the minimal or moderately
advanced cases even with the treatment of SM-INH, and also these two drugs
effect favourably for the general condition of the patients as body weight, X-ray
findings, appetite and so on, the SM-INH therapy may be recommended for those
patients.
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